Study on the Efficacy of Endoscopic Radiofrequency Treatment in Reducing the Need for Blood Transfusions in GAVE

The aim of the study therefore is to permanently resolve the existence of the bleeding sites caused by Gave and reduce both bleeding episodes and the need for transfusion in such patients applying "Barrx" (trademark) radiofrequency endoscopic ablation technology in selected cohort of patients that will be defined the patient inclusion section.

NCT Number	NCT06830317
Lead Sponsor	Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis Collaborators: Medtronic
Conditions	GAVE - Gastric Antral Vascular Ectasia
Enrollment	80 participants
Start Date	2025-04-02
Primary Completion	2027-07-02 (estimated)
Study Completion	2027-09-02 (estimated)
Updated on ClinicalTrials.gov	2025-02-17